New York Life Investment Management »

Inhibrx shares owned by New York Life Investment Management

Quarter-by-quarter ownership of Inhibrx (INBX) shares owned by New York Life Investment Management from 13F filings

Historical chart of New York Life Investment Management investment in Inhibrx

Tip: Access up to 7 years of quarterly data

All positions including Inhibrx held by New York Life Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inhibrx by New York Life Investment Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.4M 41k 34.96
2022-12-31 $627k 26k 24.64
2022-09-30 $405k 23k 17.93
2022-06-30 $238k 21k 11.37

More positions owned by New York Life Investment Management

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Indexiq Etf Tr Candriam Us Larg (IQSU)
Amazon (AMZN)
Indexiq Active Etf Tr Iq Mackay Esg Cr (ESGB)
Indexiq Etf Tr Candriam Us Mid (IQSM)
Indexiq Etf Tr Iq 500 Int Etf (IQIN)
Indexiq Etf Tr Candriam Interna (IQSI)
Meta Platforms Cl A (META)
Ishares Tr Fltg Rate Nt Etf (FLOT)
Indexiq Etf Tr Iq U.s. Small Ca (CSML)
Alphabet Cap Stk Cl A (GOOGL)
Indexiq Etf Tr Iq Cbre Nexgen (ROOF)
Indexiq Etf Tr Ftse Internl Eqt (HFXI)

View all positions for New York Life Investment Management

Top funds holding Inhibrx

Viking Global Investors
Perceptive Advisors
BlackRock
RA Capital Management
Vanguard Group
Sofinnova Ventures
Citadel Advisors
Alpine Associates Management
Arrowpoint Asset Management
Walleye Trading Advisors
Bank of America Corporation
Geode Capital Management
Tang Capital Management
Morgan Stanley
Qube Research & Technologies

View all funds holding Inhibrx